vs
雅培（ABT）与LG化学（CHE）财务数据对比。点击上方公司名可切换其他公司
雅培的季度营收约是LG化学的27.3倍（$11.5B vs $420.0M）。LG化学净利率更高（15.8% vs 15.5%，领先0.3%）。雅培同比增速更快（4.4% vs 3.1%）。过去两年雅培的营收复合增速更高（7.2% vs 5.9%）
雅培是总部位于美国伊利诺伊州雅培园的跨国医疗健康企业，业务覆盖美国境外市场药品销售、诊断产品、营养产品及医疗器械等板块，在全球医疗健康领域拥有较高的行业知名度与广泛的市场覆盖。
LG化学是韩国最大的化工企业，总部位于韩国首尔，2021年按销售额统计为全球第九大化工企业。其前身为生产化妆品的乐喜化学工业株式会社，目前已全面转型为仅面向企业客户的B2B经营模式。
ABT vs CHE — 直观对比
营收规模更大
ABT
是对方的27.3倍
$420.0M
营收增速更快
ABT
高出1.3%
3.1%
净利率更高
CHE
高出0.3%
15.5%
两年增速更快
ABT
近两年复合增速
5.9%
损益表 — Q4 2025 vs Q1 2026
| 指标 | | |
|---|---|---|
| 营收 | $11.5B | $420.0M |
| 净利润 | $1.8B | $66.3M |
| 毛利率 | 57.0% | — |
| 营业利润率 | 19.6% | 20.1% |
| 净利率 | 15.5% | 15.8% |
| 营收同比 | 4.4% | 3.1% |
| 净利润同比 | -80.8% | -7.6% |
| 每股收益（稀释后） | $1.01 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABTCHE
| Q1 26 | — | $420.0M | ||
| Q4 25 | $11.5B | $639.3M | ||
| Q3 25 | $11.4B | $624.9M | ||
| Q2 25 | $11.1B | $618.8M | ||
| Q1 25 | $10.4B | $646.9M | ||
| Q4 24 | $11.0B | $411.0M | ||
| Q3 24 | $10.6B | $391.4M | ||
| Q2 24 | $10.4B | $374.6M |
净利润ABTCHE
| Q1 26 | — | $66.3M | ||
| Q4 25 | $1.8B | $76.8M | ||
| Q3 25 | $1.6B | $64.2M | ||
| Q2 25 | $1.8B | $52.5M | ||
| Q1 25 | $1.3B | $71.8M | ||
| Q4 24 | $9.2B | $90.3M | ||
| Q3 24 | $1.6B | $75.8M | ||
| Q2 24 | $1.3B | $70.9M |
毛利率ABTCHE
| Q1 26 | — | — | ||
| Q4 25 | 57.0% | 35.2% | ||
| Q3 25 | 55.4% | 31.5% | ||
| Q2 25 | 56.4% | 29.8% | ||
| Q1 25 | 56.9% | 33.5% | ||
| Q4 24 | 55.0% | 1.2% | ||
| Q3 24 | 55.8% | -1.2% | ||
| Q2 24 | 55.6% | -4.1% |
营业利润率ABTCHE
| Q1 26 | — | 20.1% | ||
| Q4 25 | 19.6% | 15.7% | ||
| Q3 25 | 18.1% | 12.0% | ||
| Q2 25 | 18.4% | 11.0% | ||
| Q1 25 | 16.3% | 14.6% | ||
| Q4 24 | 17.4% | 27.7% | ||
| Q3 24 | 17.5% | 23.5% | ||
| Q2 24 | 16.1% | 23.5% |
净利率ABTCHE
| Q1 26 | — | 15.8% | ||
| Q4 25 | 15.5% | 12.0% | ||
| Q3 25 | 14.5% | 10.3% | ||
| Q2 25 | 16.0% | 8.5% | ||
| Q1 25 | 12.8% | 11.1% | ||
| Q4 24 | 84.1% | 22.0% | ||
| Q3 24 | 15.5% | 19.4% | ||
| Q2 24 | 12.5% | 18.9% |
每股收益（稀释后）ABTCHE
| Q1 26 | — | — | ||
| Q4 25 | $1.01 | $5.45 | ||
| Q3 25 | $0.94 | $4.46 | ||
| Q2 25 | $1.01 | $3.57 | ||
| Q1 25 | $0.76 | $4.86 | ||
| Q4 24 | $5.26 | $6.00 | ||
| Q3 24 | $0.94 | $5.00 | ||
| Q2 24 | $0.74 | $4.65 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.9B | $16.9M |
| 总债务越低越好 | $12.9B | $91.2M |
| 股东权益账面价值 | $52.1B | $848.0M |
| 总资产 | $86.7B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.25× | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资ABTCHE
| Q1 26 | — | $16.9M | ||
| Q4 25 | $8.9B | $74.5M | ||
| Q3 25 | $7.7B | $129.8M | ||
| Q2 25 | $7.3B | $249.9M | ||
| Q1 25 | $6.8B | $173.9M | ||
| Q4 24 | $8.0B | $178.3M | ||
| Q3 24 | $7.8B | $238.5M | ||
| Q2 24 | $7.2B | $222.9M |
总债务ABTCHE
| Q1 26 | — | $91.2M | ||
| Q4 25 | $12.9B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $14.1B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益ABTCHE
| Q1 26 | — | $848.0M | ||
| Q4 25 | $52.1B | $979.4M | ||
| Q3 25 | $51.0B | $1.1B | ||
| Q2 25 | $50.6B | $1.2B | ||
| Q1 25 | $48.8B | $1.2B | ||
| Q4 24 | $47.7B | $1.1B | ||
| Q3 24 | $39.8B | $1.2B | ||
| Q2 24 | $39.3B | $1.2B |
总资产ABTCHE
| Q1 26 | — | $1.5B | ||
| Q4 25 | $86.7B | $1.5B | ||
| Q3 25 | $84.2B | $1.6B | ||
| Q2 25 | $84.0B | $1.7B | ||
| Q1 25 | $81.4B | $1.7B | ||
| Q4 24 | $81.4B | $1.7B | ||
| Q3 24 | $74.4B | $1.8B | ||
| Q2 24 | $73.0B | $1.7B |
负债/权益比ABTCHE
| Q1 26 | — | 0.11× | ||
| Q4 25 | 0.25× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.30× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.3B | $88.2M |
| 自由现金流经营现金流 - 资本支出 | $2.6B | — |
| 自由现金流率自由现金流/营收 | 22.9% | — |
| 资本支出强度资本支出/营收 | 6.0% | 4.1% |
| 现金转化率经营现金流/净利润 | 1.87× | 1.33× |
| 过去12个月自由现金流最近4个季度 | $7.4B | — |
8季度趋势，按日历期对齐
经营现金流ABTCHE
| Q1 26 | — | $88.2M | ||
| Q4 25 | $3.3B | $133.5M | ||
| Q3 25 | $2.8B | $83.4M | ||
| Q2 25 | $2.0B | $138.6M | ||
| Q1 25 | $1.4B | $32.7M | ||
| Q4 24 | $2.9B | $164.9M | ||
| Q3 24 | $2.7B | $90.5M | ||
| Q2 24 | $2.0B | $77.5M |
自由现金流ABTCHE
| Q1 26 | — | — | ||
| Q4 25 | $2.6B | $117.2M | ||
| Q3 25 | $2.3B | $66.0M | ||
| Q2 25 | $1.5B | $122.8M | ||
| Q1 25 | $933.0M | $19.5M | ||
| Q4 24 | $2.1B | $152.2M | ||
| Q3 24 | $2.1B | $77.0M | ||
| Q2 24 | $1.4B | $66.5M |
自由现金流率ABTCHE
| Q1 26 | — | — | ||
| Q4 25 | 22.9% | 18.3% | ||
| Q3 25 | 20.2% | 10.6% | ||
| Q2 25 | 13.9% | 19.8% | ||
| Q1 25 | 9.0% | 3.0% | ||
| Q4 24 | 19.6% | 37.0% | ||
| Q3 24 | 20.2% | 19.7% | ||
| Q2 24 | 13.8% | 17.7% |
资本支出强度ABTCHE
| Q1 26 | — | 4.1% | ||
| Q4 25 | 6.0% | 2.6% | ||
| Q3 25 | 4.4% | 2.8% | ||
| Q2 25 | 4.5% | 2.6% | ||
| Q1 25 | 4.7% | 2.1% | ||
| Q4 24 | 6.6% | 3.1% | ||
| Q3 24 | 5.2% | 3.5% | ||
| Q2 24 | 5.1% | 3.0% |
现金转化率ABTCHE
| Q1 26 | — | 1.33× | ||
| Q4 25 | 1.87× | 1.74× | ||
| Q3 25 | 1.70× | 1.30× | ||
| Q2 25 | 1.15× | 2.64× | ||
| Q1 25 | 1.07× | 0.46× | ||
| Q4 24 | 0.31× | 1.83× | ||
| Q3 24 | 1.64× | 1.19× | ||
| Q2 24 | 1.51× | 1.09× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ABT
暂无分部数据
CHE
| Homecare | $371.1M | 88% |
| Inpatient | $35.9M | 9% |
| Other | $13.0M | 3% |
